Citations

Citations to this article as recorded by  

• Impact of Health Financing on Healthcare Quality and Affordability in Malaysia: A Conceptual Review
  Daan-Max van Dongen
  Malaysian Journal of Medical and Biological Research.2022; 9(1): 33.     CrossRef
• Explaining specific taxes management and use in the health sector: a qualitative study
  Mahdi Kooshkebaghi, Sara Emamgholipour, Hossein Dargahi
  BMC Health Services Research.2022;[Epub]     CrossRef
• Leveraging ambulatory care pharmacist expertise in medication appeals to overcome access barriers: A descriptive report
  Christopher Hvisdas, Natalie Goode, Kevin Lee, Diane Kim, Michael Silvey, Nishaminy Kasbekar
  JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.2022; 5(11): 1128.     CrossRef
• Cost considerations for clinicians prescribing biologic drugs: Who pays?
  Christopher Hvisdas, Patrick K. Gleeson, Andrea J. Apter
  Journal of Allergy and Clinical Immunology.2020; 146(2): 266.     CrossRef
• Medication adherence and cost‐related medication non‐adherence in patients with rheumatoid arthritis: A cross‐sectional study
  Parvaneh Heidari, Wendy Cross, Carolina Weller, Mohammadali Nazarinia, Kimberley Crawford
  International Journal of Rheumatic Diseases.2019; 22(4): 555.     CrossRef
• 21st-century capitalism: structural challenges for universal health care
  Susan K. Sell
  Globalization and Health.2019;[Epub]     CrossRef
• Transition of Health Financing and Cost Risk-Sharing and Risk-Pooling Models in the Health Sector: A Systematic Review (1990 - 2019)
  Ali Ahangar, AliMohammad Ahmadi, AmirHossein Mozayani, Sajjad FarajiDizaji, Samaneh Safarani
  Iranian Red Crescent Medical Journal.2019;[Epub]     CrossRef